MUSTANG BIO, INC.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$2.4M | -$16.2M | -$49.3M | -$76.2M | -$66.7M |
| Operating expenses | $2.4M | $16.2M | $49.3M | $76.2M | $66.7M |
| Cash from operations | -$5.3M | -$11.4M | -$49.5M | -$65.1M | -$53.7M |
| Capital expenditure | — | $0 | $64,000 | $2.7M | $4.0M |
| Free cash flow | — | -$11.4M | -$49.5M | -$67.8M | -$57.7M |
| Impairments | $0 | $3.7M | $0 | — | — |
| Total assets | $17.6M | $9.3M | $17.7M | $92.4M | $125.2M |
| Total liabilities | $8.1M | $13.2M | $17.6M | $46.1M | $12.8M |
Shares outstanding 7.6M · Free float 89.2%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.